Press release
A Deep Dive into Chronic Hepatitis B Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034
Chronic Hepatitis B Market Report
The size of the chronic hepatitis B market has consistently expanded over recent years. From $3.77 billion in 2024, it is forecasted to reach a value of $3.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%. The growth observed during the historic period is owed to developments in antiviral treatment, increased efforts by government and non-government organizations, advancements in diagnostic methods, a higher incidence of HIV, and heightened public awareness.
The market for chronic hepatitis B is set for stable expansion in the forthcoming years. The prediction is that by 2029, it will surge to $4.65 billion, driven by a compound annual growth rate (CAGR) of 4.2%. Factors fueling this predicted increment during the forecast years include growth in developing markets, enhanced government initiatives and financial support, upgraded diagnostic procedures and screenings, an increase in healthcare expenses, escalating strategic alliances and partnerships, a rising elderly population, and expanded public awareness campaigns. Notable future trends include a pivot towards curative treatment, advancement in emergent markets, refined diagnostic and screening processes, collaborations and partnerships, and an emphasis on patient-oriented care.
What Factors Are Fueling Growth in the Chronic Hepatitis B Market?
The escalating instance of chronic Hepatitis B infection is likely to fuel the expansion of the chronic Hepatitis B virus market. Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV), which can be averted with vaccination. The surge in Hepatitis B infection rates is a result of several factors, particularly in low to middle income countries, where low vaccination penetration leads to higher transmission rates due to a significant part of the populace remaining unprotected. A rise in Hepatitis B infection can stimulate demand for diagnostic procedures and treatment alternatives. For example, according to a report released by the US government agency, Centers for Disease Control and Prevention (CDC) in June 2024, elevating worldwide Hepatitis B vaccination coverage to 90% and access to treatment to 80% could ward off 26 million fresh infections and 9 million fatalities due to Hepatitis B between 2022 and 2050. In 2022, there were 1.2 million fresh incidences of Hepatitis B virus (HBV) infection. Therefore, the escalating prevalence of Hepatitis B infection is predicted to accelerate the growth of the chronic Hepatitis B virus market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17112&type=smp
Which Key Market Leaders Are Driving Chronic Hepatitis B Industry Growth?
Major companies operating in the chronic hepatitis b market are Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals
What Are the Emerging Trends in the Chronic Hepatitis B Industry?
The trend in the chronic hepatitis B industry sees numerous large corporations dedicating their resources to escalating technical progress, such as cutting-edge antiviral treatments. These novel antiviral therapies employ new medical strategies to target particularly resistant viral infections, halting their replication with the assistance of sophisticated delivery systems. Various clinical trials are in progress to assess these therapies for safety and efficacy, including bepirovirsen for chronic hepatitis B treatment. To illustrate, GSK plc, a multinational pharmaceutical and biotechnology corporation based in the UK with wide-ranging expertise in research, product development, manufacturing, and marketing, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for bepirovirsen in February 2024. This experimental antisense oligonucleotide (ASO) aims to treat chronic hepatitis B by specifically targeting and breaking down the hepatitis B virus's (HBV) RNA, which could potentially enable the body's immune system to regain control and neutralize the infection. The drug has shown promising outcomes in Phase IIb trials, namely the B-Clear and B-Sure studies, demonstrating efficiency in diminishing hepatitis B surface antigen levels and achieving ongoing viral suppression.
What Are the Main Segments in the Chronic Hepatitis B Market?
The chronic hepatitis B market covered in this report is segmented -
1) By Drug Class: Antivirals, Immune Modulators
2) By Gender: Male, Female
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Antivirals: Nucleos(T)Ide Analogs (Tenofovir, Entecavir), Interferons (Pegylated Interferon)
2) By Immune Modulators: Immune Checkpoint Inhibitors, Therapeutic Vaccines (HBV Vaccines Under Development)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chronic-hepatitis-b-global-market-report
Which Geographic Area Leads the Chronic Hepatitis B Market?
North America was the largest region in the chronic hepatitis B market in 2023. The regions covered in the chronic hepatitis b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Chronic Hepatitis B Global Market Report?
- Market Size Analysis: Analyze the Chronic Hepatitis B Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Chronic Hepatitis B Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Chronic Hepatitis B Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Chronic Hepatitis B Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17112
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Deep Dive into Chronic Hepatitis B Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here
News-ID: 3858820 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
